RT Journal Article
SR Electronic
T1 Epidemiological waves - types, drivers and modulators in the COVID-19 pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.07.21268513
DO 10.1101/2022.01.07.21268513
A1 Harvey, John
A1 Chan, Bryan
A1 Srivastava, Tarun
A1 Zarebski, Alexander E.
A1 Dłotko, Paweł
A1 Błaszczyk, Piotr
A1 Parkinson, Rachel H.
A1 White, Lisa J.
A1 Aguas, Ricardo
A1 Mahdi, Adam
YR 2022
UL http://medrxiv.org/content/early/2022/01/07/2022.01.07.21268513.abstract
AB Introduction A discussion of ‘waves’ of the COVID-19 epidemic in different countries is a part of the national conversation for many, but there is no hard and fast means of delineating these waves in the available data and their connection to waves in the sense of mathematical epidemiology is only tenuous.Methods We present an algorithm which processes a general time series to identify substantial, significant and sustained periods of increase in the value of the time series, which could reasonably be described as ‘observed waves’. This provides an objective means of describing observed waves in time series.Results The output of the algorithm as applied to epidemiological time series related to COVID-19 corresponds to visual intuition and expert opinion. Inspecting the results of individual countries shows how consecutive observed waves can differ greatly with respect to the case fatality ratio. Furthermore, in large countries, a more detailed analysis shows that consecutive observed waves have different geographical ranges. We also show how waves can be modulated by government interventions and find that early implementation of non-pharmaceutical interventions correlates with a reduced number of observed waves and reduced mortality burden in those waves.Conclusion It is possible to identify observed waves of disease by algorithmic methods and the results can be fruitfully used to analyse the progression of the epidemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by UK Research & Innovation [grant number EP/W012294/1].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involves only openly available human data, which can be obtained from: https://github.com/covid19db https://ourworldindata.org/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://github.com/covid19db https://ourworldindata.org/ https://github.com/covid19db